4 results
Approved WMOCompleted
Primary Safety Objective: To describe the safety profile of 20vPnC
Approved WMOCompleted
* The purpose of this study is to to determine the safety profile of long-termCoversin treatment.* To observe the long term safety and efficacy of Coversin over periods in excess of 6 months* To assess the long term patient acceptability of Coversin…
Approved WMOCompleted
Primary purpose: study the feasibility of a new treatment option based on biofeedback in people with intellectual disabilities.Secondary purpose: explore effects of treatment for swallowing problems in people with intellectual disabilities.
Approved WMOCompleted
To determine the safety and efficacy of coversin in the treatment of patients with PNH resistant to eculizumab.